Antisoma Plc is an investment holding and management company. Its principal activity is investing in and growth and development of businesses which present opportunities for value creations. The company currently intends to indentify investment opportunities offering the potential to deliver a favorable return to shareholders over the medium term, primarily in the form of capital gain. Previously the company was engaged in cancer drug development business. Antisoma was founded in 1988 and is headquartered in London, the United Kingdom.
Mitre House 160 Aldersgate Street
London, LO EC1A 4DD
SIC Code: 6799